Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer
View ORCID ProfileAmit Sud, Michael Jones, View ORCID ProfileJohn Broggio, Stephen Scott, View ORCID ProfileChey Loveday, Bethany Torr, View ORCID ProfileAlice Garrett, David L. Nicol, View ORCID ProfileShaman Jhanji, Stephen A. Boyce, Matthew Williams, Georgios Lyratzopoulos, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, Mark Lawler, View ORCID ProfileDavid C. Muller, Muti Abulafi, View ORCID ProfileRichard Houlston, Clare Turnbull
doi: https://doi.org/10.1101/2020.04.28.20083170
Amit Sud
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Michael Jones
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
John Broggio
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
Stephen Scott
3RM Partners, West London Cancer Alliance, London, UK
Chey Loveday
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Bethany Torr
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Alice Garrett
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
David L. Nicol
4Urology Unit, Royal Marsden NHS Foundation Trust, London, UK
5Department of Clinical Studies, Institute of Cancer Research, London, UK
Shaman Jhanji
6Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
7Division of Cancer Biology, Institute of Cancer Research, London, UK
Stephen A. Boyce
8Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Matthew Williams
9Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK
10Computational Oncology Group, Imperial College London, London, UK
Georgios Lyratzopoulos
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
11Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, University College London, London, UK
Claire Barry
3RM Partners, West London Cancer Alliance, London, UK
Elio Riboli
12School of Public Health, Imperial College London
Emma Kipps
3RM Partners, West London Cancer Alliance, London, UK
13The Breast Unit, Royal Marsden NHS Foundation Trust, London, UK
Ethna McFerran
14Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast
Mark Lawler
14Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast
David C. Muller
12School of Public Health, Imperial College London
Muti Abulafi
15Colorectal Surgery, Croydon Health Services NHS Trust, on behalf of RMP NICE FIT Steering Group
Richard Houlston
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
16Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
Clare Turnbull
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
16Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
Data Availability
This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of Public Health England (PHE).
Posted May 05, 2020.
Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer
Amit Sud, Michael Jones, John Broggio, Stephen Scott, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Matthew Williams, Georgios Lyratzopoulos, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, Mark Lawler, David C. Muller, Muti Abulafi, Richard Houlston, Clare Turnbull
medRxiv 2020.04.28.20083170; doi: https://doi.org/10.1101/2020.04.28.20083170
Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer
Amit Sud, Michael Jones, John Broggio, Stephen Scott, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Matthew Williams, Georgios Lyratzopoulos, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, Mark Lawler, David C. Muller, Muti Abulafi, Richard Houlston, Clare Turnbull
medRxiv 2020.04.28.20083170; doi: https://doi.org/10.1101/2020.04.28.20083170
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2347)
- Dermatology (206)
- Emergency Medicine (376)
- Epidemiology (11723)
- Forensic Medicine (10)
- Gastroenterology (697)
- Genetic and Genomic Medicine (3701)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2379)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3462)
- Nursing (195)
- Nutrition (520)
- Oncology (1805)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1023)
- Primary Care Research (416)
- Public and Global Health (6104)
- Radiology and Imaging (1264)
- Respiratory Medicine (822)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)